Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

    Home > Events > Veristat to exhibit at outsourcing in clinical trials southeast 2016

    1 min read

    Veristat to Exhibit at Outsourcing in Clinical Trials Southeast 2016

    Join Veristat and outsourcing experts from biotech, pharma and medical device industries at the Outsourcing in Clinical Trials Southeast 2016 conference to discuss, deliberate and debate the latest operational and outsourcing challenges in conducting clinical trials.

    Are you interested in exploring new techniques for designing and executing your clinical trials? Talk with Veristat’s experts and attend the conference presentations discussing adaptive design, risk-based monitoring, electronic data capture and more.

    The event will cover many topics that Veristat is well-versed in including:

    • Outsourcing in oncology - trials, tribulations and triumphs
    • Exploring personalized medicines: Drugs performing optimally in rare diseases or narrowly defined subpopulations of common and heterogeneous diseases
    • Harnessing real-time data to optimize site and patient recruitment
    • Enhancing relationships and collaboration between sponsors and vendors
    • Maximizing your Phase I and Phase II data to ensure a smooth Phase III
    • Tackling your international multi-centre clinical trial – do’s and don’ts and everything in between

    Schedule A Meeting with Veristat

    Don’t forget to stop by Veristat’s booth #8 to speak with our experts about your upcoming needs in 2016.   Click to schedule a meeting with us at the event or anytime that works for you!

    Schedule Meeting_Blue

     

    Share This Event:

       

    11 min read

    Monthly FDA Guidance and Regulatory News Review - September 2026

    This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...

    8 min read

    Monthly FDA Guidance and Regulatory News Review - August 2026

    This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...